CTRI/2023/10/058931
Not yet recruiting
未知
Randomized Controlled clinical trial of the efficacy of Ela Churna (Elettaria Cardamomum) Pratisarana with Madhu in the management of Vataja Mukhapakaw.s.r. Aphthous stomatitis - NI
Ayurveda Mahavidyalaya Graduate Research Centre0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: K121- Other forms of stomatitis
- Sponsor
- Ayurveda Mahavidyalaya Graduate Research Centre
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)PATIENT WILLING TO SIGN WRITTEN CONSENT
- •2\)PATIENT WITH SYMPTOMS OF VATAJA MUKHAPAK i.e. SHUSHKA VRANA IN MOUTH , TAMRA VRANA AT LIP , VEDANA , SHEET SPARSHASAHATVA OF JIVHA
- •3\)IRRESPECTIVE WITH SEX , RELIGION, OCCUPATIO
Exclusion Criteria
- •1\.Patient with symptoms Pittaj \& Kaphaj Mukhapak like Daha, kandu, Vrana Pichhil vrana or ksharokshat Vrana.
- •2\.K/C/O CA Oral cavity, Syphilis, AIDS, Herpes, Dengue hemorrhagic fever, DM, HTN.
- •3\.K/C/O Traumatic stomatitis, Drug induced stomatitis
- •4\.Lactating \& pregnant women.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Randomized controlled clinical trial of the efficacy of the digital self-help program edupression.com® in mild-to-moderate unipolar depressive patientsF32.0F33.0F32.1F33.1Mild depressive episodeRecurrent depressive disorder, current episode mildModerate depressive episodeRecurrent depressive disorder, current episode moderateDRKS00032121Medizinische Universität Wien250
Completed
Phase 3
Seroquel compared to Risperidone in the treatment of psychotic disorders adolescents.ACTRN12605000556640Dr Harith Swadi60
Completed
Not Applicable
Randomized controlled trial of 4-hour versus 24-hour nasogastric rehydration in children with acute gastroenteritis and moderate dehydratioAcute viral gastroenteritis with moderate dehydrationOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12610000737033Royal Children's Hospital Melbourne426
Completed
Not Applicable
Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter studytype 2 diabetic patients with NAFLD/NASHJPRN-UMIN000015727Saga University55
Completed
Phase 2
Ayurvedic Management on Type II Diabetes Mellitus.Health Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2019/02/017609Khobarkar Punam Self80